MARKET

NVNO

NVNO

Envveno Medical Corporation
NASDAQ
11.85
+1.86
+18.62%
After Hours: 9.95 -1.9 -16.03% 19:01 02/20 EST
OPEN
10.27
PREV CLOSE
9.99
HIGH
12.32
LOW
10.27
VOLUME
41.65K
TURNOVER
--
52 WEEK HIGH
196.70
52 WEEK LOW
8.67
MARKET CAP
7.77M
P/E (TTM)
-0.3132
1D
5D
1M
3M
1Y
5Y
1D
BRAEDEN LICHTI- NORTHSTRIVE'S FUND RECOMMENDATIONS TO ENVVENO MEDICAL'S BOARD TO IMMEDIATELY HALT ALL CLINICAL OPERATIONS
Reuters · 13h ago
BRAEDEN LICHTI- NORTHSTRIVE'S FUND RECOMMENDATIONS TO ENVVENOS BOARD TO LAUNCH FORMAL STRATEGIC REVIEW TO EITHER RETURN CAPITAL OR PURSUE MERGER
Reuters · 13h ago
BRAEDEN LICHTI- NORTHSTRIVE FUND HAS REQUESTED TO MEET WITH SENIOR MANAGEMENT OF ENVVENO MEDICAL IN BOARD LETTER
Reuters · 13h ago
BRAEDEN LICHTI- REPORTS 5.05% STAKE IN ENVVENO MEDICAL CORP AS OF FEB 20 - SEC FILING
Reuters · 13h ago
Weekly Report: what happened at NVNO last week (0209-0213)?
Weekly Report · 4d ago
Weekly Report: what happened at NVNO last week (0202-0206)?
Weekly Report · 02/09 10:15
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans
TipRanks · 02/04 14:00
enVVeno Medical regains compliance with Nasdaq minimum bid price rule
TipRanks · 02/04 13:46
More
About NVNO
enVVeno Medical Corporation is a late clinical-stage medical device company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe chronic venous insufficiency (CVI) of the deep venous system of the leg. The Company’s lead product is the VenoValve, which is a surgical replacement venous valve that is being evaluated in a U.S. pivotal study. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The Company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the veins of the leg, and back to the heart and lungs.

Webull offers enVVeno Medical Corp stock information, including NASDAQ: NVNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVNO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVNO stock methods without spending real money on the virtual paper trading platform.